A recent study of 36 pathologists examining 50 HER2-stained cancers, all previously reported as HER2 IHC 0, demonstrated poor concordance in categorising HER2-null and HER2-ultralow with a Fleiss κ score of only 0.230 [55]. This evidence concerns the gene ERBB2 and cancer.